{{medical}}
{{DISPLAYTITLE:<small>L</small>-多巴}}
{{Expand |time=2011-09-14T18:31:12+00:00 }}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 415564129
| IUPAC_name = (''S'')-2-amino-3-(3,4-dihydroxyphenyl)<br />propanoic acid
| image = 3,4-Dihydroxy-L-phenylalanin (Levodopa).svg
| width = 200
| image2 = Levodopa3D.PNG
| drug_name = <small>L</small>-DOPA

<!--Clinical data-->
| tradename =  
| pregnancy_AU = B3
| pregnancy_US = C
| legal_status = OTC
| routes_of_administration = oral

<!--Pharmacokinetic data-->
| bioavailability = 30%
| metabolism = [[Aromatic-L-amino-acid_decarboxylase|Aromatic-L-amino-acid decarboxylase]]
| elimination_half-life = 0.75–1.5 hours
| excretion = [[renal|renal]] 70–80%

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|CAS}}
| CAS_number = 59-92-7
| ATC_prefix = N04
| ATC_suffix = BA01
| PubChem = 6047
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = APRD00309
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5824
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 46627O600J
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00059
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 15765
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1009

<!--Chemical data-->
| C=9 | H=11 | N=1 | O=4 
| molecular_weight = 197.19 g/mol
| smiles = O=C(O)[C@@H](N)Cc1cc(O)c(O)cc1
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = WTDRDQBEARUVNC-LURJTMIESA-N
}}
[[File:Catecholamines_biosynthesis_(zh-cn).svg|thumb]]
'''<small>L</small>-多巴<ref>[http://www.term.gov.cn/pages/homepage/result2.jsp?id=334770&subid=10001798&subject=%E6%96%B0%E9%99%88%E4%BB%A3%E8%B0%A2&subsys=%E7%94%9F%E7%89%A9%E5%8C%96%E5%AD%A6%E4%B8%8E%E5%88%86%E5%AD%90%E7%94%9F%E7%89%A9%E5%AD%A6]{{dead link|date=2017年11月 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>'''（{{lang-en|<small>L</small>-DOPA}}，全称'''3,4-二羟苯丙氨酸'''）是[[酪氨酸|酪氨酸]]经[[酪氨酸羟化酶|酪氨酸羟化酶]]的作用下羟化产生的一种氧化产物，具有[[儿茶酚|儿茶酚]]羟基，可进一步生成另外一些有生物活性的物质：<small>L</small>-多巴在[[酪氨酸酶|酪氨酸酶]]的作用下生成[[多巴醌|多巴醌]]继而自发转变为[[黑色素|黑色素]]，或在[[芳香族氨基酸脱羧酶|芳香族氨基酸脱羧酶]]的作用下生成[[多巴胺|多巴胺]]，继而形成[[去甲肾上腺素|去甲肾上腺素]]与[[肾上腺素|肾上腺素]]等。
==参考文献==
{{reflist}}
* {{cite journal | author=Waite, J. Herbert, et al. | title=Mussel Adhesion: Finding the Tricks Worth Mimicking | journal=J Adhesion | volume=81 | year=2005 | pages=1–21 | doi=10.1080/00218460590944602}}
* {{cite journal | author=Messersmith, Phillip B., et al. | title=Rapid Gel Formation and Adhesion in Photocurable and Biodegradable Block Copolymers with High DOPA Content | journal=Macromolecules | volume=39 | year=2006 | pages=1740–1748 | doi=10.1021/ma0518959}}

==外部链接==
* [http://www.sciencedaily.com/releases/2006/08/060816024159.htm Study Reveals Details Of Mussels' Tenacious Bonds] {{Wayback|url=http://www.sciencedaily.com/releases/2006/08/060816024159.htm |date=20190703140731 }}

{{抗帕金森病}}
{{氨基酸代谢酶类}}
{{Antiobesity preparations}}
{{Aphrodisiacs}}
{{Neurotransmitter metabolism intermediates}}

[[分類:α-胺基酸|分類:α-胺基酸]]
[[分類:致焦虑剂|分類:致焦虑剂]]
[[分類:儿茶酚胺|分類:儿茶酚胺]]
[[分類:前药|分類:前药]]
[[分類:世界卫生组织基本药物|分類:世界卫生组织基本药物]]